A New Diagnostic Method to Assess Paclitaxel-Induced Peripheral Neuropathy

NCT04237194 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2022-08-24

No results posted yet for this study

Summary

To assess the impact of Paclitaxel treatment on the nerve excitability of the small and large nerve fibers

Conditions

  • Chemotherapy-induced Peripheral Neuropathy

Sponsors & Collaborators

  • Aalborg University Hospital

    collaborator OTHER
  • Carsten Dahl Mørch

    lead OTHER

Principal Investigators

  • Laurids Ø Poulsen, MD, PhD · Aalborg University Hospital

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2023-12-30
Completion
2024-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04237194 on ClinicalTrials.gov